Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,266 public trials 688 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Active, Not Recruiting

M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

NCT02595931

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Colonic Diseases, +42 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Keck Medical Center of USC Pasadena Pasadena, California, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLC

NCT04606771

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +15 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Sacramento, California, United States
  • Research Site Ciudad de Buenos Aires, Argentina
  • Research Site Delhi, India
View all 21 locations
View Trial Details
Active, Not Recruiting

Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

NCT04784715

Conditions
Breast Cancer; HER2-positive; Metastatic, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Springdale, Arkansas, United States
  • Research Site Glendale, California, United States
  • Research Site Glendale, California, United States
View all 283 locations
View Trial Details
Active, Not Recruiting

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

NCT03793166

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 860 locations
View Trial Details
Active, Not Recruiting

Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.

NCT06506955

Conditions
Adenocarcinoma, Advanced/Metastatic Cancer, Carcinoma, +8 more
Locations
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Institut Paoli-Calmettes Marseille, France
  • Institut De Cancerologie Strasbourg Strasbourg, France
  • Severance Hospital Seoul, South Korea
View Trial Details
Active, Not Recruiting

Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study

NCT04258137

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • Centre hospitalier de la Côte Basque Bayonne, France
  • Clinique Tivoli-Ducos Bordeaux, France
  • Institut Bergonie Bordeaux, France
  • Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
View Trial Details
Active, Not Recruiting

A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors

NCT03693014

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +25 more
Locations
  • Hartford Healthcare Hartford, Connecticut, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer

NCT05476796

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +12 more
Locations
  • Clinique de l'Europe Amiens, France
  • Hopital Privé Arras Les Bonnettes Arras, France
  • Institut Sainte Catherine Avignon, France
  • Centre Hospitalier de Beauvais Beauvais, France
View all 28 locations
View Trial Details

Related conditions